Genomics company Pacific Biosciences of California (NASDAQ:PACB) will be announcing earnings results tomorrow after market ...

After the National Institutes of Health (NIH) announced late Friday that it would be following a Trump administration ...

Barclays lowered the firm’s price target on 10x Genomics to $18 from $19 and keeps an Overweight rating on the shares. The firm expects the ...

Barclays analyst Luke Sergott lowered the firm’s price target on Bruker to $65 from $69 and keeps an Overweight rating on the shares. The firm ...

Illumina is estimated to have around 80% of the global DNA sequencing market, with Element one of a new generation of rivals alongside the likes of PacBio and Singular Genomics, which launched ...

Cathie Wood's ARK ETFs have disclosed their daily trades for Monday, February 10th, 2025, with notable transactions across a range of technology and biotech stocks. The largest trade of the day ...

After China placed Illumina on a government watchlist this week, in response to new tariffs imposed by the Trump ...

Welcome to the fourth quarter 2024 Illumina earnings conference call. (Operator Instructions) Please be advised that today's conference is being recorded. I would now like to hand the conference ...

Gene sequencing machine maker Illumina forecast 2025 revenue largely below Wall Street estimates on Thursday, signaling ...

The local gene-sequencing company and a U.S. clothing company face sales restrictions in China as part of that country’s ...

Good day, ladies and gentlemen and welcome to the Fourth Quarter 2024 Illumina Earnings Conference Call. [Operator Instructions] Please be advised that today's conference is being recorded.